195 related articles for article (PubMed ID: 20409619)
1. [Treatment of immune thrombocytopenia: a retrospective study of 40 patients].
Audia S; Lakomy D; Guy J; Leguy-Seguin V; Berthier S; Aho S; Lorcerie B; Bonnotte B
Rev Med Interne; 2010 May; 31(5):337-44. PubMed ID: 20409619
[TBL] [Abstract][Full Text] [Related]
2. ITP and international guidelines: what do we know, what do we need?
Rodeghiero F; Ruggeri M
Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
[TBL] [Abstract][Full Text] [Related]
3. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
4. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
Zaja F; Marin L; Chiozzotto M; Puglisi S; Volpetti S; Fanin R
Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome of immune thrombocytopenia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2012 Oct; 153(41):1613-21. PubMed ID: 23045311
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
8. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
9. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
[TBL] [Abstract][Full Text] [Related]
10. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
Ghanima W; Khelif A; Waage A; Michel M; Tjønnfjord GE; Romdhan NB; Kahrs J; Darne B; Holme PA;
Lancet; 2015 Apr; 385(9978):1653-61. PubMed ID: 25662413
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
[TBL] [Abstract][Full Text] [Related]
12. [Immune thrombocytopenias: pathophysiology and treatment].
Godeau B
Bull Acad Natl Med; 2013 Feb; 197(2):407-17. PubMed ID: 24919370
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in pathophysiology and treatment of immune thrombocytopenia].
Kashiwagi H; Tomiyama Y
Rinsho Ketsueki; 2015 Feb; 56(2):177-84. PubMed ID: 25765798
[TBL] [Abstract][Full Text] [Related]
14. Reemergence of Splenectomy for ITP Second-line Treatment?
Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of adult's immune thrombopenia (ITP)].
Khellaf M
Rev Med Interne; 2010 Dec; 31 Suppl 3():S329-32. PubMed ID: 21056519
[No Abstract] [Full Text] [Related]
16. Sequence of treatments for adults with primary immune thrombocytopenia.
George JN
Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
[TBL] [Abstract][Full Text] [Related]
17. Treatment of immune thrombocytopenic purpura in adults.
Bussel J
Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
[TBL] [Abstract][Full Text] [Related]
18. Immune thrombocytopenia: no longer 'idiopathic'.
McCrae K
Cleve Clin J Med; 2011 Jun; 78(6):358-73. PubMed ID: 21632906
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Gómez-Almaguer D
Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with refractory immune thrombocytopenic purpura.
George JN
J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
